Topics

Here's Why You Need To Keep An Eye On These Biotech Stocks

05:09 EDT 11 Mar 2019 | RTTNews

The clinical trial results of a drug company can impact its stock price depending upon the outcome - and more so if it is a small-/mid-cap biopharma stock. A keen understanding of the target timeline of the clinical trials will help trade biotech stocks with some margin of safety around the catalyst events.

Original Article: Here's Why You Need To Keep An Eye On These Biotech Stocks

NEXT ARTICLE

More From BioPortfolio on "Here's Why You Need To Keep An Eye On These Biotech Stocks"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...